Comorbidities associated with COPD in the middle East and North Africa region: Association with severity and exacerbations

International Journal of COPD

Volumn 11, Issue , 2016, Pages 273-280

  Mahboub, Bassam ^a   Alzaabi, Ashraf ^b   Iqbal, Mohammed Nizam ^c   Salhi, Hocine ^d   Lahlou, Aïcha ^e   Tariq, Luqman ^f   Hasnaoui, Abdelkader El ^f  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b ZAYED MILITARY HOSPITAL   (United Arab Emirates)

^c RASHID HOSPITAL   (United Arab Emirates)

^d Foxymed   (France)

^e MS Health   (Morocco)

^f GLAXOSMITHKLINE   (United Arab Emirates)

Author keywords

Cardiovascular disease; Comorbidity; COPD exacerbation; Diabetes; MENA region

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MIDDLE AGED; MIDDLE EAST; NORTH AFRICA; PAKISTAN; POPULATION RESEARCH; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SYMPTOM; WELLBEING; AFRICA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DISEASE COURSE; LUNG FUNCTION TEST; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX;

ADULT; AFRICA, NORTHERN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PAKISTAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SYMPTOM FLARE UP;

EID: 84957565310     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S90626     Document Type: Article

References (29)

1. GOLD (Global initiative for chronic Obstructive Lung Disease). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda (MD): GOLD; 2011
2. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969
3. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–962
4. Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in chronic obstructive pulmonary disease: systematic literature review. Chest. 2013;144(4):1163–1178
5. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: WHO; 2008
6. World Health Organization. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. Geneva: WHO; 2007
7. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185
8. Baty F, Putora PM, Isenring B, Blum T, Brutsche M. Comorbidities and burden of COPD: a population based case-control study. PloS One. 2013;8(5):e63285
9. de Miguel Diez J, Carrasco Garrido P, García Carballo M, et al. Determinants and predictors of the cost of COPD in primary care: a Spanish perspective. Int J Chron Obstruct Pulmon Dis. 2008;3(4):701–712
10. Tageldin MA, Nafti S, Khan JA, et al. Distribution of COPD-related symptoms in the Middle East and North Africa region: results of the BREATHE study. Respir Med. 2012;106 Suppl 2:S25–S32
11. Khattab A, Javed A, Iraqui G, et al. Smoking habits in the Middle East and North Africa region: results of the BREATHE study. Respir Med. 2012;106 Suppl 2:S16–S24
12. World Health Organization. Prevalence of tobacco use among adults and adolescents. 2012. Available from: http://gamapserver.who.int/gho/interactive_charts/tobacco/use/atlas.html. Accessed December 1, 2015
13. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels: IDF; 2012
14. Sherif S, Sumpio BE. Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison. World J Diabetes. 2015;6(2):304–311
15. Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011;31(1):19–23
16. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
17. El Hasnaoui A, Rashid N, Lahlou A, Salhi H, Doble A, Nejjari C. Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study. Respir Med. 2012;106 Suppl 2:S3–S15
18. Idrees M, Koniski ML, Taright S, et al. Management of chronic obstructive pulmonary disease in the Middle East and North Africa region: results of the BREATHE study. Respir Med. 2012;106 Suppl 2: S33–S44
19. Jones PW, Shahrour N, Nejjari C, et al. Psychometric evaluation of the COPD Assessment Test (CAT): data from the BREATHE study in the Middle East and North Africa region. Respir Med. 2012;106 Suppl 2: S86–S99
20. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257
21. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12:26
22. Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475
23. Health Authority Abu Dhabi. Health Statistics 2011. Abu Dhabi: HAAD; 2012
24. Almagro P, Castro A. Helping COPD patients change health behavior in order to improve their quality of life. Int J Chron Obstruct Pulmon Dis. 2013;8:335–345
25. Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007; 5:52
26. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD – its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33–37
27. Rascon-Aguilar IE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest. 2006;130(4): 1096–1101
28. Walter RE, Wilk JB, Larson MG, et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest. 2008;133(1):19–25
29. Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation? Prim Care Respir J. 2008;17(4):199–205.